ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Mayo’s Regional Program – Keys To Success Are Service, Communications

December 9, 1977

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

Obama Signs Bill Giving FDA Authority Over Tobacco Products

June 26, 2009

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

GM Prizes Awarded To Gleevec Pioneers Druker, Lydon, And To Peto, Sulston, Waterston

June 7, 2002